HIGHFDA DRUG

K.C. Pharmaceuticals Sterile Eye Drops Recall 315,144 Bottles for Lack of Sterility (2026)

K.C. Pharmaceuticals recalled 315,144 sterile eye drop bottles distributed nationwide after lack of sterility. The products span several brands including GNP Eye Drops Redness and Dry Eye Relief, Leader Eye Drops Redness Relief, and Foster & Thrive Redness Relief Eye Drops. Consumers should stop using the products immediately and follow guidance from KC Pharmaceuticals or their healthcare provider

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
March 3, 2026
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
March 3, 2026
Hazard Level
HIGH
Brands
GNP Eye Drops Redness and Dry Eye Relief, Leader Eye Drops Redness Relief, Foster and Thrive Redness Relief Eye Drops
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
GNP Eye Drops Redness and Dry Eye Relief, Leader Eye Drops Redness Relief, Foster and Thrive Redness Relief Eye Drops
Product type
Sterile Eye Drops
Model numbers
RL24D01, RL24F01, RL24F02
UPC codes
46122-606, 70000-0010, 70677-1161, 46122-606-05, 70000-0010-1, 70000-0010-2, 70677-1161-1, 11822-6453-4
Sizes
0.5 fl oz (15 mL)
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    March 3, 2026

  2. Reported by FDA DRUG

    April 8, 2026

  3. RecallRadar source check

    April 15, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Lack of Assurance of Sterility

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact K.C. Pharmaceuticals, Inc or your healthcare provider for guidance. Notification method: E-Mail

About This Product

These eye drops are marketed as sterile relief for redness and dryness. They are sold under multiple brand names and distributed across the United States by various distributors.

Why This Is Dangerous

A sterility lapse means the product could be contaminated, potentially causing eye infections or injuries if used.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Impact includes a large nationwide distribution of recalled bottles. The primary risk is potential eye infection or irritation from non-sterile product.

Practical Guidance

How to identify if yours is affected

  1. Check if your bottle is 0.5 fl oz (15 mL).
  2. Look for brand names listed: GNP Eye Drops Redness and Dry Eye Relief, Leader Eye Drops Redness Relief, Foster and Thrive Redness Relief Eye Drops.
  3. Verify lot numbers RL24D01 or RL24F01 RL24F02 and Exp. dates 04/30/26 or 06/30/26.

Where to find product info

Recall details available on FDA enforcement page and the notice from KC Pharmaceuticals.

What timeline to expect

4-8 weeks for refund or replacement processing once arranged.

If the manufacturer is unresponsive

  • File a complaint with the FDA's MedWatch program for adverse events.
  • Consult your healthcare provider for guidance and possible alternative products.

How to prevent similar issues

  • Beware of sterile eye drop products from unfamiliar brands.
  • Always check packaging for the exact lot numbers and expiry dates before use.
  • Purchase eye drops from reputable retailers and keep recall information handy.

Documentation advice

Retain the product, packaging, and recall notice. Save all correspondence with KC Pharmaceuticals and your healthcare provider.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Sterile Eye Drops Redness Relief Lubricant (glycerin 0.25% and napahazoline HCl 0.012%), 0.5 fl oz (15 mL). Size: 0.5 fl oz (15 mL). Brands involved: GNP Eye Drops Redness and Dry Eye Relief; Leader Eye Drops Redness Relief; Foster and Thrive Redness Relief Eye Drops. Distributors and packaging identifiers include KC Pharmaceuticals, Inc and nationwide distributors such as AmerisourceBergen, Cardinal Health, Grandall Distributing Co., Walgreens, McKesson Corp., UNFI, Rite Aid, Discount Drug Mart. UPC/NDcs and packaging identifiers include: UPC 130209; NDC 46122-606-05; Colirio Ojo

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 315,144 bottles recalled nationwide
  • Class II recall for lack of sterility
  • Brands include GNP Eye Drops Redness and Dry Eye Relief, Leader Eye Drops Redness Relief, Foster and
  • Thrive Redness Relief Eye Drops
  • Lot numbers RL24D01 RL24F01 RL24F02 and Exp dates 04/30/26 and 06/30/26
  • Distributed by AmerisourceBergen, Cardinal Health, Grandall, Walgreens, McKesson, UNFI, Rite Aid, Dd

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
RL24D01
RL24F01
RL24F02
UPC Codes
46122-606
70000-0010
70677-1161
+5 more
Affected States
ALL
Report Date
April 8, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more